Getinge (GETI B.ST) Akcija Kursas
Getinge Kursas
Pajamos augo 5,3 % per metus per pastaruosius 19 metus iki 34,97 mlrd. SEK. Pelnas akcijai augo 3,1 % per metus per pastaruosius 19 metus. Getinge grynoji marža dabar yra 6,5 %, sumažėjo nuo 11,0 % prieš kelerius metus. Getinge šiuo metu siūlo apie 1,66 % dividendo pajamingumą. Išmokų koeficientas yra apie 55 % pelno. Dividendas augo 4,7 % per metus per pastaruosius 19 metus. Analitikų tikslinės kainos mediana yra 231,03 SEK, t. y. žemiau dabartinę kainą 16,8 %. Iš 14 analitikų 8 rekomenduoja pirkti — bendras konsensusas yra Pirkti.
Getinge akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Getinge akcija ir akcijų analizė
Dažnai užduodami klausimai apie Getinge akciją
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analitikai šiuo metu nustato vidutinę Getinge akcijos tikslinę kainą 238,81 SEK (mediana: 231,03 SEK), t. y. −14,4 % palyginti su paskutine kaina. Konsensusas pagrįstas 14 analitikų reitingais.
14 analitikai šiuo metu vertina Getinge akciją: 8 rekomenduoja pirkti, 5 laikyti ir 1 parduoti. 2026 m. analitikai tikisi, kad Getinge gaus 35,26 mlrd. SEK pajamų ir 12,89 SEK pelno akcijai.
Pagal dabartinį kursą Getinge akcija kainuoja 25,20 EUR (277,80 SEK).
Getinge akcija (GETI B.ST) kotiruojama 9 biržose, įskaitant: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
tikėtina pelnas Getinge yra 35,26 mlrd. SEK. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas Getinge yra 3,51 mlrd. SEK. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Getinge šiuo metu yra 21,56. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Getinge akcijos vertę.
Kainų ir pardavimų santykis (KUV) Getinge šiuo metu yra 2,15. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Getinge akcijos įvertinimo metrika.
Eulerpool kokybės balas Getinge yra 4/10.
Getinge ISIN yra SE0000202624. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Getinge WKN yra 889714. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Getinge prekybos žymė yra GETI B.ST. Ši biržos žymė naudojama Getinge akcijoms prekiauti biržoje.
Getinge akcija
Getinge Pagrindiniai konkurentai
Getinge Biržos simbolis
Getinge FIGI
Visos Getinge pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Getinge akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Getinge. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: